Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Global Healthcare Today.
Press releases published on October 21, 2025
NEW BOOK DEBUNKS MIDLIFE MYTHS AND EMPOWERS PATIENTS DURING WORLD MENOPAUSE MONTH
Arizona naturopathic doctor delivers a clear, evidence-informed guide to hormone health for women and men, just in time for World Menopause Month PARADISE VALLEY, AZ, UNITED STATES, October 21, 2025 /EINPresswire.com/ -- Fatigue. Brain fog. Mood swings. …
ABL Diagnostics Expands Global Footprint with Additional Exclusive Distribution Partnerships in Cyprus and Montenegro
WOIPPY, FRANCE, October 21, 2025 /EINPresswire.com/ -- ABL Diagnostics (FR001400AHX6 – ABLD, the “Company”), a Euronext-listed leader in molecular diagnostics, is pleased to announce the appointment of two additional exclusive distribution partners to …
Primes-maladie 2026 : des écarts du simple au double pour les mêmes prestations
En 2026, 37% des assuré(e)s verront leur prime-maladie grimper de plus de 6%, avec des hausses pouvant atteindre 38% selon le profil. LAUSANNE, VAUD, SWITZERLAND, October 21, 2025 /EINPresswire.com/ -- En 2026, 37% des assuré(e)s verront leur prime- …
Krankenkassenprämien 2026: Unterschiede bis zum Doppelten für gleiche Leistungen
In 2026 werden 37% der Versicherten eine Erhöhung ihrerPrämien um mehr als 6% erfahren, wobei die Erhöhungen je nach Profil bis zu 38% betragen können. LAUSANNE, VAUD, SWITZERLAND, October 21, 2025 /EINPresswire.com/ -- In 2026 werden 37% der …
VIDAC PHARMA HOLDING PLC Plans Inclusion of Its Shares in the Open Market of the Düsseldorf Stock Exchange
The planned inclusion aims to enhance share tradability and facilitate future access to XETRA trading. Vidac Pharma PLC (XSTU:T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ) LONDON, UNITED KINGDOM, October 21, 2025 /EINPresswire.com/ -- VIDAC PHARMA HOLDING PLC …
Exercise counteracts junk food's depression-like effects through gut-brain metabolic signaling
Researchers reveal how running mitigates cafeteria diet-induced behavioral changes in rats. The findings identify mechanisms linking lifestyle to mental health CORK, MUNSTER, IRELAND, October 21, 2025 /EINPresswire.com/ -- Researchers led by Professor …
ZEELOOL Partners with Prabal Gurung for Exclusive Collaboration
The latest collection of ZEELOOL X Prabal Gurung perfect blends timeless design into the charm of modern. AUSTIN, TX, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- The latest collection of ZEELOOL X Prabal Gurung perfect blends timeless design …
Following World Menopause Day, Yi TCM Urges Women to Watch Gum Health as a Hidden Symptom of Hormonal Imbalance
In conjunction with World Menopause Day 2025, Yi TCM urges awareness of gum inflammation and sensitivity to detect hormonal imbalances in menopausal women. SINGAPORE, SINGAPORE, October 21, 2025 /EINPresswire.com/ -- There is a growing concern among …
IVDR Consultancy Expanded Globally by I3CGLOBAL for In Vitro Diagnostic Manufacturers
IVDR Consultancy by I3CGLOBAL expands to help global IVD manufacturers achieve CE Marking compliance under EU IVDR 2017/746 efficiently. NEW DELHI, DELHI, INDIA, October 21, 2025 /EINPresswire.com/ -- I3CGLOBAL, a global leader in medical device and in …
Care GP to scale Agentic AI for Healthcare Ops to 7,000 GP clinics nationally
Australian AI startup Care GP expands nationally after 140% MoM growth and zero churn across 150 GP clinics. SYDNEY, NSW, AUSTRALIA, October 21, 2025 /EINPresswire.com/ -- Care GP, an Australian Healthcare AI startup building Agentic AI for healthcare …
JUARA Joins Global Beauty Leaders at Beautyworld Middle East 2025
JUARA will join Beautyworld Middle East 2025, taking place from October 27–29 at the Dubai World Trade Centre. NEW YORK, NY, UNITED STATES, October 20, 2025 /EINPresswire.com/ -- JUARA, the skincare brand rooted in Indonesia’s Jamu wellness tradition, …
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer, Philip Beer, will be presenting data on the identification …
Eleva advances CPV-104 into Phase 1b clinical testing in patients with C3G, following the successful completion of single ascending dose evaluation in healthy volunteers
CPV-104 is the only recombinant Factor H in clinical development and has received EU Orphan Drug Designation for C3G Eleva successfully completed the Single Ascending Dose part of the First-in-Human clinical trial evaluating CPV-104 in healthy volunteers …
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
– Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response rate, sustained improvement in desmoid tumor symptoms and consistent safety profile – STAMFORD, Conn., Oct. 21, …
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO® (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany, announced today that long-term efficacy and safety data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat), an …
PIVOT-PO Phase 3 Data Show Tebipenem HBr’s Potential as the First Oral Carbapenem Antibiotic for Patients with Complicated Urinary Tract Infections (cUTIs)
Data presented at IDWeek 2025 after study stopped early for efficacy Primary endpoint met, demonstrating non-inferiority of oral tebipenem HBr compared to intravenous treatment1 Data will be shared with regulatory authorities to support regulatory filings …
Galapagos Announces Intention to Wind Down Cell Therapy Business as Part of the Company’s Ongoing Transformation
Intention follows comprehensive strategic review process and would represent the optimal capital allocation pathway to support a stronger and sustainable future for Galapagos Mechelen, Belgium; October 21, 2025, 07:30 CET; regulated information – inside …
Galapagos kondigt intentie aan om celtherapieactiviteiten af te bouwen als onderdeel van de voortdurende transformatie van het bedrijf
Deze intentie volgt na een uitgebreid strategisch evaluatieproces en zou de meest optimale manier zijn om kapitaal toe te wijzen ter ondersteuning van een sterkere en duurzame toekomst voor Galapagos Mechelen, België; 21 oktober 2025, 07:30 CET; …
Phonak’s AI revolution continues: new Infinio Ultra hearing aids with clearer sound and easier maintenance
STÄFA, Switzerland, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Phonak, a global leader in innovative hearing solutions, introduces Infinio Ultra, the next step in tackling two core challenges for hearing aid users: speech clarity from any direction and wax …
Disc Medicine Announces Pricing of $250 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants
WATERTOWN, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ: IRON) (Disc), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious …